Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine/Prilocaine Cream vs Lidocaine/Tetracaine Ointment for Anesthesia Prior to Laser Treatment
NCT04523961Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2021
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray, prilocaine and tetracaine in pain (2 arms), sponsored by Mayo Clinic. Primary endpoint: Self-reported Pain After Laser Treatment at 60 minutes. Started Jan 2021; status: completed.
02
Drugs
lidocaine 10% oropharyngeal sprayprilocainetetracaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04523961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04523961.